Inspire Investing’s 10x Genomics TXG Stock Holding History

Inspire Investing’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,275	Closed	-$322K	–	728
2020 Q4	$322K	Buy	+2,275	New	+$330K	0.07%	407

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Inspire Investing's TXG Position: Q1 2021 in Review

Inspire Investing sold out of 10x Genomics (TXG) in Q1 2021, closing a stake of 2,275 shares — an estimated $322K sold.

Inspire Investing first reported a position in TXG in Q4 2020 and held it in 1 quarter. The position peaked at $322K in Q4 2020. 324 funds tracked by Wall St. Rank hold TXG as of Q1 2021.

Inspire Investing reported no remaining 10x Genomics position as of Q1 2021 after selling out during the quarter.
Inspire Investing sold 2,275 10x Genomics shares in Q1 2021, an estimated $322K.
Inspire Investing first reported a position in 10x Genomics in Q4 2020 and held it in 1 quarter.
Inspire Investing's 10x Genomics position peaked at $322K in Q4 2020.
324 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2021.

Based on Inspire Investing's 13F filing for Q1 2021, filed 30 Apr 2021.